Search results

Articles (7)

Journals (0)

1-7 of 7 results for Exelon

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessResearch articleFirst published January, 2017

Understanding Human Over-reliance on Technology;It's Exelan,Not Exelon;Crash Cart Drug Mix-up;Risk with Entering a “Test Order”

Michael R. Cohen, Judy L. Smetzer

Hospital Pharmacy

Free accessResearch articleFirst published September, 2017

Bioequivalence Study of Rivastigmine 6 mg Capsules (Single Dose) in Healthy Volunteers

Dhiraj Abhyankar, Ashish Shedage, Milind Gole [...]

American Journal of Alzheimer's Disease & Other Dementias®

Restricted accessResearch articleFirst published September 13, 2022

Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System

Kun Bu, Devashru Patel, Robert Morris [...]

Journal of Alzheimer’s Disease

Free accessReview articleFirst published September, 2011

Rivastigmine in Alzheimer’s Disease and Parkinson’s Disease Dementia

Daniel Weintraub, Monique Somogyi, Xiangyi Meng

American Journal of Alzheimer's Disease & Other Dementias®

Restricted accessResearch articleFirst published September, 2008

Into the New Millennium and Out of the Ordinary the Development of Millennium Park

Rachel Brewer

Collections: A Journal for Museum and Archives Professionals

Free accessReview articleFirst published March, 2018

Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer’s Disease

Vinod Kaushik, Sarah Toombs Smith, Emmanuel Mikobi [...]

American Journal of Alzheimer's Disease & Other Dementias®

Free accessResearch articleFirst published September, 2013

Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on Instrumental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease

George Grossberg, Jeffrey Cummings, Lutz Frölich [...]

American Journal of Alzheimer's Disease & Other Dementias®

Search results

Articles (7)

Journals (0)

1-7 of 7 results for Exelon

Sort by:

Relevance

Select all

Sort by:

Relevance

Restricted accessResearch articleFirst published January, 2017

Understanding Human Over-reliance on Technology;It's Exelan,Not Exelon;Crash Cart Drug Mix-up;Risk with Entering a “Test Order”

Michael R. Cohen, Judy L. Smetzer

Hospital Pharmacy

Free accessResearch articleFirst published September, 2017

Bioequivalence Study of Rivastigmine 6 mg Capsules (Single Dose) in Healthy Volunteers

Dhiraj Abhyankar, Ashish Shedage, Milind Gole [...]

American Journal of Alzheimer's Disease & Other Dementias®

Restricted accessResearch articleFirst published September 13, 2022

Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System

Kun Bu, Devashru Patel, Robert Morris [...]

Journal of Alzheimer’s Disease

Free accessReview articleFirst published September, 2011

Rivastigmine in Alzheimer’s Disease and Parkinson’s Disease Dementia

Daniel Weintraub, Monique Somogyi, Xiangyi Meng

American Journal of Alzheimer's Disease & Other Dementias®

Restricted accessResearch articleFirst published September, 2008

Into the New Millennium and Out of the Ordinary the Development of Millennium Park

Rachel Brewer

Collections: A Journal for Museum and Archives Professionals

Free accessReview articleFirst published March, 2018

Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer’s Disease

Vinod Kaushik, Sarah Toombs Smith, Emmanuel Mikobi [...]

American Journal of Alzheimer's Disease & Other Dementias®

Free accessResearch articleFirst published September, 2013

Efficacy of Higher Dose 13.3 mg/24 h Rivastigmine Patch on Instrumental Activities of Daily Living in Patients with Mild-to-Moderate Alzheimer's Disease

George Grossberg, Jeffrey Cummings, Lutz Frölich [...]

American Journal of Alzheimer's Disease & Other Dementias®